Prevalence of MAFLD in the U.S. based on NHANES 2009–2018: differences in demographic characteristics, physical indices and lifestyle conditions
Open Access
- 2 May 2025
- journal article
- research article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 25 (1) , 1-10
Abstract
The incidence of metabolic dysfunction-associated fatty liver disease (MAFLD) is high among U.S. adults, but studies on its occurrence in different ethnic and age groups are limited. The aim of the present study was to assess MAFLD occurrence among the U.S. adults by considering demographic characteristics, physical indices, and lifestyle conditions. This study utilized the National Health and Nutrition Examination Survey (NHANES) data 2009–2018 from 23,546 participants aged ≥ 20 years. Variables such as age, sex, race, body mass index (BMI), waist circumference (WC), blood pressure, sedentary behavior, sleep, and depression were analyzed. Among 9933 participants, 3562 had MAFLD (34.1%), with notably higher percentages of Mexican-Americans (54.1%) and lower percentages of blacks (20.5%). The incidence of MAFLD was significantly greater (P < 0.001) in males (39%) than in females (29.2%), which was particularly evident within the 36–40 years age group. The MAFLD incidence exhibited an age-dependent pattern, initially increasing and subsequently declining (except for whites). Compared to white MAFLD patients, black MAFLD patients exhibited greater BMI, WC, systolic blood pressure (SBP), and diastolic blood pressure (DBP) values, whereas values for these measures were lower among Mexican–American patients. Logistic regression analysis adjusting for age and sex revealed that depression was more common among MAFLD patients (P < 0.001), except for severe depression (P > 0.05). Notably, the MAFLD incidence was not significantly associated with sedentary behavior or sleep duration. The MAFLD incidence varies across different racial, age, and sex groups, and targeted interventions are essential for reducing the burden of MAFLD. However, further research is necessary to explore the correlations among MAFLD incidence, sleep patterns, and an inactive lifestyle.Keywords
All Related Versions
Funding Information
- Shanghai Municipal Health Commission (JKKPYL-2022-15)
- Key Discipline Projects of Huadong Hospital (LCZX220)
- Shanghai Outstanding Young Medical Personnel Training Program (20224Z0009)
- Key Specialized Diseases Construction of Huadong Hospital (ZDZB2225)
- Shanghai Leading Talent Program of Eastern Talent Plan Class A (002)
- Shanghai Municipal Health Commission Guidance Fund for Integrated Traditional Chinese and Western Medicine (ZXXT-202302)
This publication has 41 references indexed in Scilit:
- Mechanisms Linking Metabolic-Associated Fatty Liver Disease (MAFLD) to Cardiovascular DiseaseCurrent Hypertension Reports, 2023
- An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLDClinical Gastroenterology and Hepatology, 2023
- Association between depression and metabolic dysfunction-associated fatty liver disease/significant fibrosisJournal of Affective Disorders, 2023
- Prevalence, characteristics, and mortality outcomes of obese and nonobese MAFLD in the United StatesHepatology International, 2022
- Differential Clinical Characteristics and Mortality Outcomes in Persons With NAFLD and/or MAFLDClinical Gastroenterology and Hepatology, 2021
- Reassessment of the Hispanic Disparity: Hepatic Steatosis Is More Prevalent in Mexican Americans Than Other HispanicsHepatology Communications, 2021
- Lean non-alcoholic fatty liver disease and risk of incident diabetes in a euglycaemic population undergoing health check-ups: A cohort studyDiabetes & Metabolism, 2021
- Prevalence of Liver Steatosis and Fibrosis Detected by Transient Elastography in Adolescents in the 2017–2018 National Health and Nutrition Examination SurveyClinical Gastroenterology and Hepatology, 2021
- Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and DepressionHepatology Communications, 2020
- 17β-estradiol ameliorates lipotoxicity-induced hepatic mitochondrial oxidative stress and insulin resistanceFree Radical Biology and Medicine, 2020